FDA
-
-
-
-
-
-
-
Teleflex (TFX) Reports Preliminary Results from IDE Study on Ringer Perfusion Balloon Catheter
-
-
-
-
-
-
-
Teleflex (TFX) PT Raised to $235 at Truist Securities
-
-
-
-
-
-
-
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
-
-
-
-
-
-
-
Teleflex to Acquire Palette Life Sciences
-
-
-
-
-
-
-
Teleflex Selects GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement Material for Use with Innovative Titan SGS® Stapler
-
-
-
-
-
-
-
Teleflex (TFX) Announces Worldwide Recall of Gibeck Iso-Gard Filter
-
-
-
-
-
-
-
Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures
-
322,198 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

